Form 4: IGM Biosciences Director Acquires Shares as Part of Compensation Policy

Director Jakob Haldor Topsoe acquires 828 shares of IGM Biosciences common stock as part of a quarterly retainer, while Topsoe Holding A/S holds a significant indirect ownership.

Summary

• On March 31, 2025, Jakob Haldor Topsoe, a director of IGM Biosciences, acquired 828 shares of common stock.
• The acquisition was part of a quarterly retainer paid in common stock, according to the Issuer's Outside Director Compensation Policy.
• The price per share was $0.
• Following the transaction, Topsoe directly owns 90,884 shares of IGM Biosciences common stock.
• Topsoe Holding A/S, of which Jakob Haldor Topsoe is a board member, indirectly holds 10,400,564 shares.
• The board members of Topsoe Holding A/S may be deemed to share voting and investment power but disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects routine compensation rather than a significant market transaction or strategic shift.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction increases the director's alignment with shareholder interests.

Key Dates

Keywords

IGM Biosciences, Jakob Haldor Topsoe, Director, Share Acquisition, Common Stock, Topsoe Holding A/S, Beneficial Ownership, Compensation Policy